Lipid-lowering therapy after myocardial infarction: the Bavarian Cholesterol Screening Project.
作者信息
Richter W O, Schwandt P
出版信息
JAMA. 1998 Aug 19;280(7):603-4. doi: 10.1001/jama.280.7.603.
PMID:9718050
Abstract
摘要
相似文献
1
Lipid-lowering therapy after myocardial infarction: the Bavarian Cholesterol Screening Project.心肌梗死后的降脂治疗：巴伐利亚胆固醇筛查项目
JAMA. 1998 Aug 19;280(7):603-4. doi: 10.1001/jama.280.7.603.
2
Editorial: Lipid-lowering drugs after myocardial infarction.社论：心肌梗死后的降脂药物
Lancet. 1975 Mar 1;1(7905):501-2.
3
Secondary prevention of coronary disease with lipid-lowering drugs.
Lancet. 1989 Mar 4;1(8636):473-4.
4
Gemfibrozil to prevent myocardial infarction.吉非贝齐预防心肌梗死。
Ann Intern Med. 1998 Nov 1;129(9):750. doi: 10.7326/0003-4819-129-9-199811010-00026.
5
Increasing prescription of drugs for secondary prevention of myocardial infarction. Lipid lowering drugs should be considered too.增加用于心肌梗死二级预防的药物处方。还应考虑使用降脂药物。
BMJ. 1996 Jan 27;312(7025):252. doi: 10.1136/bmj.312.7025.252b.
6
Effects of lipid lowering on coronary plaques and coronary events.
Am J Cardiol. 1997 Oct 30;80(8B):8H-9H.
7
The effect of intensive lipid lowering on coronary atheroma and clinical outcome.强化降脂对冠状动脉粥样硬化及临床结局的影响。
Heart. 2007 Feb;93(2):149-51. doi: 10.1136/hrt.2006.105676. Epub 2006 Oct 11.
8
[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].[确定高脂血症类型对动脉粥样硬化趋脂治疗的重要性]
Kardiologiia. 1973 Mar;13(3):27-33.
9
Testing the efficacy of lipid-lowering therapy versus revascularization: the time has come, or is it past due?测试降脂治疗与血管重建术的疗效：时机已到，还是早已逾期？
Circulation. 1998 Jun 30;97(25):2584-6. doi: 10.1161/01.cir.97.25.2584.
10
A case for lipid lowering? Response to Dr Paul Durrington.
Diabet Med. 2001 May;Suppl 3:11-2. doi: 10.1046/j.1464-5491.2001.00001-5.x.
Zotero 插件